Chicagoland IL
Regeneron 'antibody cocktail' helps prevent COVID-19, trial results show
SAN FRANCISCO (KRON) - Phase 3 trial results by biotech company Regeneron showed its new drug provides long-term protection against COVID-19. A single dose of the antibody cocktail…
